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Abstract
What started out as a mere attempt to tentatively identify proteins in experimen-
tal cancer-related 2D-PAGE maps developed into VIRTUAL2D, a web-accessible
repository for theoretical pI/MW charts for 92 organisms. Using publicly available
expression data, we developed a collection of tissue-speciﬁc plots based on differential
gene expression between normal and diseased states. We use this comparative cancer
proteomics knowledge base, known as the tissue molecular anatomy project (TMAP),
to uncover threads of cancer markers common to several types of cancer and to relate
this information to established biological pathways. Published in 2004 by John Wiley
&S o n s ,L t d .
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Introduction
The recent sequencing and subsequent analysis of
the human genome have enabled a paradigm shift:
increasingly, efforts are being directed away from
a microscopy-based histopathology approach and
towards molecular proﬁling for diagnosis and man-
agement of diseases such as cancer. This approach
promises to improve the likelihood of positive out-
come by early detection and selection of the appro-
priate therapeutic intervention. One way to achieve
this is to use computer-aided pattern recognition
algorithms to look for signatures of markers on the
basis of signiﬁcant differential expression between
normal and altered states. This formidable chal-
lenge relies on high-resolution separation and anal-
ysis methods.
Despite being gradually complemented and
sometimes replaced by liquid chromatography
(LC) techniques, two-dimensional polyacrylamide
gel electrophoresis (2D-PAGE) [9] has enjoyed
remarkable staying power. In the span of
three decades, it has evolved from a multi-
process, labour-intensive separation technique to an
automated, highly reproducible and sensitive tool
that has often been at the core of efforts aimed
at the detection of disease-speciﬁc biomarkers.
However, large-scale identiﬁcation of proteins
remains a pricey proposition, as it is typically
carried out in conjunction with tandem mass
spectrometry (MS), driving the cost per spot to
exceed several hundred Euros. SWISS2D is the
largest publicly accessible repository of such data,
yet the number of identiﬁed spots represents less
than a few per cent of the full complement
of proteins predicted by the genome sequencing
projects. We constructed two databases that address
some of these issues, more speciﬁcally intended to:
• Facilitate the protein-to-spot assignment in
experimental 2D-PAGE maps.
• Optimize experimental conditions by estimating
the range of pI and MW attributes in advance.
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Materials and methods
VIRTUAL2D
VIRTUAL2D [7] is the collection of web-
accessible, fully interactive, isoelectric focusing
point/molecular mass (pI/MW) charts. These maps
have been assembled from primary sequence
contained within the combined SWISS-PROT/
TrEMBL curated proteome databases [11]. Starting
with the datasets in FASTA format released by the
European Bioinformatics Institute, electrophoretic
and mass attributes are computed for unmodiﬁed
proteins (save for signal peptides if they are
present) using the following approach:
• Scan the primary sequence of the peptide.
• Assign the pK of each contributing amino acid
and average over the entire peptide.
• Sum up all the mass contributions.
The resulting pI/Mw is then given by the ratio of:
pItot =

pKCterm +

int pKint + pKNterm

(n + 2)
(1)
and
MWtot =

i
MWi
where the pK and mass values used are the same
as in (1).
These attributes; a database Accession No.
(GenBank, SWISS-PROT), protein name and cgi
requests, are assembled into tab-delimited (ASCII-
format) ﬁles, which are then processed by a JAVA-
based graphical user interface adapted from PtPlot
[10].
In the course of building these plots, a bi-
modal distribution, centred on either side of a
relatively ‘depleted’ region around pH 7.4, was
seen to be conserved for all organisms. Randomly
generated sequences varying in length from 50
to 600 amino acids yielded a similar distribution,
consistent with a limited pK-segregated proteomic
alphabet: roughly half the internal contributing
amino acids are acidic, while the other half is basic.
Just as important is the fact that none of them have
a pK value near the depleted region around pH 7.2.
When launching or accessing VIRTUAL2D, a
left panel is presented that contains a list of
available organisms, which, when selected, will
produce an initial pI/MW map containing all the
entries found in the data ﬁle. One can zoom in
on an area of interest and click on any spot to be
transported by hyperlink to a database of choice
(default is SWISS-PROT).
To date, the pI/MW charts for 92 organisms
have been assembled from data extracted from the
published datasets. The central repository can be
accessed at http://ncisgi.ncifcrf.gov/medjahed/ or
can be requested from the author and run on a
JAVA-enabled web browser.
Comparisons of predicted and experimental
charts have yielded mixed results. For very high-
resolution gels of relatively simple organisms
such as Escherichia coli, a subset of proteins for
which the theoretical values are close to their
measured counterparts can be identiﬁed and, in
principle, be used as landmarks to align both
datasets. The large number of pre- and post-
translational modiﬁcations characteristic of more
complex, multicellular organisms makes it nearly
impossible to assign reliably the protein identity of
most spots.
TMAP
Asanextensiontothetwo-dimensionalinformation,
we have explored using the frequency of detection
or abundance of each transcript in cDNA libraries
published in the Cancer Anatomy Genome Project
(CGAP) [2] database to develop a set of tissue/his-
tology-speciﬁc protein expression maps: the Tissue
Molecular Anatomy Project (TMAP) [6].
CGAP was launched in 1996 to standardize
sample handling and procurement and to track the
molecular changes occurring in cells throughout
their progression from the normal to the cancerous
state. This effort was further enhanced by the
development of laser microdissection technology,
leading in principle, to purer cell populations.
The correlation between mRNA abundance and
protein expression level is known to be complex
and non-linear. The aim here was not to address
this issue but to simply provide a representation
that could be used to carry out a comparative
analysis between the different histological states.
The starting point of our data-mining was the list
of entries in the CGAP library from which we carry
a cross-referencing of the Expressed Sequence Tags
(EST) in UNIGENE [12] to extract a tab delimited
list of gene products, including their frequency
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Figure 1. A screenshot of TMAP rendering an example pI/MW plot of the differential expression of gene products. The
isoelectric focusing point (pI) is along the x axis, the molecular mass (MW) is along the y axis. 2148 entries are commonly
detected in pooled CGAP libraries from prostate cancer and normal (which can also be displayed separately). By dragging
the appropriate sliding controls, one can ﬁlter the output by selecting a range of differential expression. Here, opting
to look only at those entries that are at least two-fold altered reduces the number of displayed proteins to 1188. The
expression scale is colour-coded from light green (most downregulated) to bright red (most upregulated). Controls along
the axes allow one to zoom in on any part of the chart and upon enabling access to a pre-selected web-based database
of choice, one can click on the hyperlinked spots to open a new window containing all the information relevant to the
associated protein. Additional ﬁlters are accessible under the ﬁlter menu and from the graphical user interface. The plot
and a tab-delimited report can be output for further examination and/or collaborations
of detection within that library. Those transcripts,
clustered with genes of known function, have their
symbol cross-referenced against the SWISS-PROT
database. For small sets of proteins, the pI/MW
server [3] can be interrogated to produce isoelectric
focusing point and mass values. For large proteome
datasets containing tens of thousands of entries, a
perl script was developed, which is run locally,
to overcome any restrictions and inherent Internet
speed bottlenecks. It will extract from the database
a ﬂat ﬁle with Accession No., primary amino
acid sequence and other attributes such as putative
function, pathways, etc. It then computes the mass
and isoelectric focusing point, as outlined earlier.
Once again, the data ﬁle is a simple tab-delimited
format with the associated expression information.
The frequency of detection of each gene product
is used to derive normalized expression levels for
each library, so that the most abundant always has
a relative expression level of 1.0. The user can
select a grey-scale or colour-coded display of this
information.
Protplot is the software used to display these
expression maps. It has been adapted from MAEx-
plorer, an open-source JAVA-based microarray
data analysis suite [8]. It checks and loads all
the corresponding ﬁles having a .prp extension
present within the start directory. Any one of
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these or a combination thereof can be selected for
display.
In some cases, a query of the CGAP database
yields more than one library satisfying the search
criteria. This is useful in checking the variability
of a gene product across similar libraries. One
can then pool the results of some or all of the
libraries corresponding to the same tissue type and
increase the signal:noise ratio. As in any counting
experiment, noise increases as n while true signal
increases as n2.
Several ﬁlters can be applied to these inferred
protein expression maps to restrict the number of
displayed gene products and monitor their expres-
sion proﬁle across several tissues.
A word of caution to potential users: the signif-
icance of these comparisons hinges on the qual-
ity of the information in the underlying databases,
a theme of growing importance in light of the
proliferation of biological databases. Although the
entire dataset can be displayed, a transcript has
to have been detected ﬁve or more times (p <
0.05) in order to be deemed reliable enough to
be included in any comparative analysis. Not all
libraries are equally rich in their content and not
all the expression data contained within them is of
the same quality.
Analysis of differential expression can be car-
ried out between similar libraries, different dis-
ease/histological states and indeed different tissues
by dividing the normalized expression levels com-
monly found in both (Figure 1).
cDNA libraries obtained from microdissected
prostate samples contain some of the better qual-
ity CGAP datasets. Several of them originate
from the same patient and span the normal, pre-
cancerous and cancerous state. In order to establish
a transcript-based model of the progression of the
disease, it helps to classify the plausible scenarios.
Given three possible histology states, the expres-
sion level of any gene product has to adhere to one
of the nine following cases in the progression of
the disease:
1. Remain constant from normal to pre-cancer
to cancer.
2. Remain constant from normal to pre-cancer and
increase from pre-cancer to cancer.
3. Remain constant from normal to pre-cancer and
decrease from pre-cancer to cancer.
4. Increase from normal to pre-cancer and remain
constant from pre-cancer to cancer.
5. Decrease from normal to pre-cancer and remain
constant from pre-cancer to cancer.
6. Increase from normal to pre-cancer and decrease
from pre-cancer to cancer.
7. Decrease from normal to pre-cancer and
increase from pre-cancer to cancer.
8. Increase from normal to pre-cancer and increase
from pre-cancer to cancer.
9. Decrease from normal to pre-cancer and
decrease from pre-cancer to cancer.
This bookkeeping allows one to go beyond the
simple grouping of co-regulated proteins and inves-
tigate inverse correlations as well. Relations such
as these are numerous and well documented in the
literature. In the context of cancer, one such exam-
ple is p27, a putative tumour-suppressor, which is
downregulated in most human prostate cancers. In
parallel, Skp2, a component of the Skp1–Cul1–F-
box protein (SCF) ubiquitin ligase complex, was
observed to be overexpressed in the same samples
leading to the hypothesis, and subsequent experi-
mental conﬁrmation, that degradation of the former
is at least partially due to the latter [5].
To date, this comparative cancer proteomics
approach has been applied to more than 14 tissues
representing the normal, precancer and cancer
histological states. This database contains more
than 18000 gene products.
Discussion
We have presented two proteomic databases: VIR-
TUAL2D and its extension, TMAP, which attempt
to go beyond mere transcript counting by adding
functional enhancements to the analysis tools, such
as p value ﬁlters, library-pooling, etc.
It is critical when interpreting differential gene
expression datasets to use statistically sound anal-
ysis tools that take into account their reproducibil-
ity and validity. In addition to exploring ways to
model de novo functional biological relationships,
we are in the early stages of exploring ways to map
the expression data onto established pathways, an
example of which is displayed in Figure 2. It is the
hope of the present authors that as the amount and
quality of information in databases improves, tools
such as VIRTUAL2D and TMAP can facilitate the
formulation of biological hypotheses.
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Figure 2. For the commonly shared gene products, differential expression can be examined by displaying the colour-coded
ratios between the diseased state and the normal state. Using the GenMAPP package [4], Histone deacetylases found in
prostate expression data are colour-coded in the pathway adapted from KEGG and describing the cell cycle according to
their level of overexpression (HDAC6, yellow) or downregulation (HDAC1, 3, purple) in cancer vs. normal
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